146 related articles for article (PubMed ID: 9879777)
21. Effect of antiprogestins and tamoxifen on growth inhibition of MCF-7 human breast cancer cells in nude mice.
El Etreby MF; Liang Y
Breast Cancer Res Treat; 1998 May; 49(2):109-17. PubMed ID: 9696393
[TBL] [Abstract][Full Text] [Related]
22. Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines.
Journe F; Chaboteaux C; Magne N; Duvillier H; Laurent G; Body JJ
Breast Cancer Res; 2006; 8(1):R2. PubMed ID: 16417650
[TBL] [Abstract][Full Text] [Related]
23. Antiprogestin inhibition of cell cycle progression in T-47D breast cancer cells is accompanied by induction of the cyclin-dependent kinase inhibitor p21.
Musgrove EA; Lee CS; Cornish AL; Swarbrick A; Sutherland RL
Mol Endocrinol; 1997 Jan; 11(1):54-66. PubMed ID: 8994188
[TBL] [Abstract][Full Text] [Related]
24. Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells.
Perry RR; Kang Y; Greaves B
Ann Surg Oncol; 1995 May; 2(3):238-45. PubMed ID: 7641021
[TBL] [Abstract][Full Text] [Related]
25. Can transforming growth factor-beta1 and retinoids modify the activity of estradiol and antiestrogens in MCF-7 breast cancer cells?
Czeczuga-Semeniuk E; Anchim T; Dziecioł J; Dabrowska M; Wołczyński S
Acta Biochim Pol; 2004; 51(3):733-45. PubMed ID: 15448735
[TBL] [Abstract][Full Text] [Related]
26. Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells.
Huang Y; Ray S; Reed JC; Ibrado AM; Tang C; Nawabi A; Bhalla K
Breast Cancer Res Treat; 1997 Jan; 42(1):73-81. PubMed ID: 9116321
[TBL] [Abstract][Full Text] [Related]
27. Estrogenic actions of RU486 in hormone-responsive MCF-7 human breast cancer cells.
Jeng MH; Langan-Fahey SM; Jordan VC
Endocrinology; 1993 Jun; 132(6):2622-30. PubMed ID: 8504763
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of HER2 modulates bcl-2, bcl-XL, and tamoxifen-induced apoptosis in human MCF-7 breast cancer cells.
Kumar R; Mandal M; Lipton A; Harvey H; Thompson CB
Clin Cancer Res; 1996 Jul; 2(7):1215-9. PubMed ID: 9816290
[TBL] [Abstract][Full Text] [Related]
29. Anti-implantation activity of antiestrogens and mifepristone.
Dao B; Vanage G; Marshall A; Bardin CW; Koide SS
Contraception; 1996 Oct; 54(4):253-8. PubMed ID: 8922879
[TBL] [Abstract][Full Text] [Related]
30. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
Lykkesfeldt AE; Madsen MW; Briand P
Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
[TBL] [Abstract][Full Text] [Related]
31. Paradoxical regulation of Bcl-2 family proteins by 17beta-oestradiol in human breast cancer cells MCF-7.
Leung LK; Wang TT
Br J Cancer; 1999 Oct; 81(3):387-92. PubMed ID: 10507761
[TBL] [Abstract][Full Text] [Related]
32. Estrogen-dependent rapid activation of protein kinase C in estrogen receptor-positive MCF-7 breast cancer cells and estrogen receptor-negative HCC38 cells is membrane-mediated and inhibited by tamoxifen.
Boyan BD; Sylvia VL; Frambach T; Lohmann CH; Dietl J; Dean DD; Schwartz Z
Endocrinology; 2003 May; 144(5):1812-24. PubMed ID: 12697687
[TBL] [Abstract][Full Text] [Related]
33. Estrogen induces death of tamoxifen-resistant MCF-7 cells: contrasting effect of the estrogen receptor downregulator fulvestrant.
Planas-Silva MD; Waltz PK; Kilker RL
J Steroid Biochem Mol Biol; 2006 Mar; 98(4-5):193-8. PubMed ID: 16464573
[TBL] [Abstract][Full Text] [Related]
34. The antiepidermal growth factor receptor agent gefitinib (ZD1839/Iressa) improves antihormone response and prevents development of resistance in breast cancer in vitro.
Gee JM; Harper ME; Hutcheson IR; Madden TA; Barrow D; Knowlden JM; McClelland RA; Jordan N; Wakeling AE; Nicholson RI
Endocrinology; 2003 Nov; 144(11):5105-17. PubMed ID: 12960029
[TBL] [Abstract][Full Text] [Related]
35. Ubiquitin ligase c-Cbl is involved in tamoxifen-induced apoptosis of MCF-7 cells by downregulating the survival signals.
Yan SC; Liu YP; Zhang LY; Qu JL; Xu L; Liu J; Zhang Y; Hou KZ; Teng YE; Qu XJ
Acta Oncol; 2011 Jun; 50(5):693-9. PubMed ID: 21175263
[TBL] [Abstract][Full Text] [Related]
36. 4-Hydroxytamoxifen inhibits proliferation of multiple myeloma cells in vitro through down-regulation of c-Myc, up-regulation of p27Kip1, and modulation of Bcl-2 family members.
Gauduchon J; Gouilleux F; Maillard S; Marsaud V; Renoir JM; Sola B
Clin Cancer Res; 2005 Mar; 11(6):2345-54. PubMed ID: 15788686
[TBL] [Abstract][Full Text] [Related]
37. Partial antagonism between steroidal and nonsteroidal antiestrogens in human breast cancer cell lines.
Müller V; Jensen EV; Knabbe C
Cancer Res; 1998 Jan; 58(2):263-7. PubMed ID: 9443403
[TBL] [Abstract][Full Text] [Related]
38. Induction of estrogen independence of ZR-75-1 human breast cancer cells by epigenetic alterations.
van Agthoven T; van Agthoven TL; Dekker A; Foekens JA; Dorssers LC
Mol Endocrinol; 1994 Nov; 8(11):1474-83. PubMed ID: 7533260
[TBL] [Abstract][Full Text] [Related]
39. Lack of synergy between estrogen and progesterone on local IGF-I, IGFBP-3 and IGFBP-2 secretion by both hormone-dependent and hormone-independent breast cancer explants in vitro. Effect of tamoxifen and mifepristone (RU 486).
Milewicz T; Gregoraszczuk EL; Sztefko K; Augustowska K; Krzysiek J; Ryś J
Growth Horm IGF Res; 2005 Apr; 15(2):140-7. PubMed ID: 15809018
[TBL] [Abstract][Full Text] [Related]
40. Combinatorial anti-proliferative effects of tamoxifen and naringenin: The role of four estrogen receptor subtypes.
Xu Z; Huang B; Liu J; Wu X; Luo N; Wang X; Zheng X; Pan X
Toxicology; 2018 Dec; 410():231-246. PubMed ID: 30153467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
